REGEN COVERED FOR REGEN-COV (CASIRIVIMAB AND IMDEVIMAB)
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

REGEN COVERED FOR REGEN-COV (CASIRIVIMAB AND IMDEVIMAB) Trademark

Serial Number: 90831614

REGEN COVERED FOR REGEN-COV (CASIRIVIMAB AND IMDEVIMAB) is a trademark filed by REGENERON PHARMACEUTICALS, INC. on July 15, 2021. The trademark is classified under Class 36 (Insurance & Financial), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

REGENERON PHARMACEUTICALS, INC. (471 trademarks)

Tarrytown, NY 10591

Entity Type: 03

Trademark Details

Filing Date

July 15, 2021

Registration Date

Not Registered

Published for Opposition

September 7, 2021

Goods & Services

Financial administration services, namely, financial administration of a program to provide access to pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders at low or no cost to underserved populations; Financial administration services, namely, financial administration of a program to provide discounts on prescription pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders

Business administration services, namely, business administration of a program to provide access to pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders at low or no cost to underserved populations; Business administration services, namely, business administration of a program to provide discounts on prescription pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders

Medical and pharmaceutical consultation regarding pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 6, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 6, 2022 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 2, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 7, 2021 NPUB
PUBLISHED FOR OPPOSITION
Sep 7, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 18, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 2, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 2, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 2, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 2, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 2, 2021 CNEA
ASSIGNED TO EXAMINER
Jul 28, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 28, 2021 NWOS
PETITION TO DIRECTOR GRANTED
Jul 28, 2021 PCGR
ASSIGNED TO PETITION STAFF
Jul 27, 2021 APET
TEAS PETITION TO DIRECTOR RECEIVED
Jul 26, 2021 TPDR
NEW APPLICATION ENTERED
Jul 19, 2021 NWAP